GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medivir AB (LTS:0GP7) » Definitions » Market Cap

Medivir AB (LTS:0GP7) Market Cap : kr360.06 Mil (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Medivir AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medivir AB's share price for the quarter that ended in Mar. 2024 was kr2.92669. Medivir AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 112.04 Mil. Therefore, Medivir AB's market cap for the quarter that ended in Mar. 2024 was kr327.91 Mil.

Medivir AB's quarterly market cap declined from Sep. 2023 (kr477.01 Mil) to Dec. 2023 (kr420.42 Mil) and declined from Dec. 2023 (kr420.42 Mil) to Mar. 2024 (kr327.91 Mil).

Medivir AB's annual market cap declined from Dec. 2021 (kr654.32 Mil) to Dec. 2022 (kr538.68 Mil) and declined from Dec. 2022 (kr538.68 Mil) to Dec. 2023 (kr420.42 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medivir AB's Enterprise Value for Today is kr204.08 Mil.


Medivir AB Market Cap Historical Data

The historical data trend for Medivir AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivir AB Market Cap Chart

Medivir AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 445.57 295.91 654.32 538.68 420.42

Medivir AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 538.68 477.01 477.01 420.42 327.91

Competitive Comparison of Medivir AB's Market Cap

For the Biotechnology subindustry, Medivir AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medivir AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medivir AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Medivir AB's Market Cap falls into.



Medivir AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Medivir AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr4.02331*104.495
=kr420.42

Medivir AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=kr2.92669*112.042
=kr327.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medivir AB  (LTS:0GP7) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Medivir AB Market Cap Related Terms

Thank you for viewing the detailed overview of Medivir AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Medivir AB (LTS:0GP7) Business Description

Traded in Other Exchanges
Address
Lunastigen 5, PO Box 1086, 2nd floor, Huddinge, SWE, 141 22
Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there are opportunities to offer significant improvements to patients. Medivir focuses on the development of MIV-818, a prodrug that has been designed to provide a targeted anti-tumor effect in the liver while minimizing any side effects. Birinapant, a SMAC mimetic, has been out-licensed for development in combination with IGM antibodies for the treatment of solid tumors.

Medivir AB (LTS:0GP7) Headlines

No Headlines